NEW YORK (GenomeWeb News) – Shares of Illumina reached an all-time high of $91.41 in Wednesday trade on the Nasdaq before pulling back slightly to close at $90.10.
 
Meanwhile, Sequenom's shares hit a 52-week high of $17.52 during Wednesday trade, also on the Nasdaq, before closing at $17.37.
 
Illumina’s shares have been rising steadily over the past few weeks in advance of its second-quarter results being released later this month.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Seattle Times writes that pharmacogenomics testing can help choose medications that may work best for people with depression.

Researchers report that deleting one gene from butterflies affects their wing coloration patterns, according to the Washington Post.

In PNAS this week: genome sequencing of weevil symbionts, retinoid X receptor deletion in lung cancer metastasis, and more.

Sequencing could help combat foodborne illnesses, according to a blog post by Food and Drug Administration officials.